Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The Oncologist|April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCCAndrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
European Urology Focus|September 22, 2024
Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell CarcinomaEmily Wang, Eric S Rupe, Sagar S Mukhida, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
ESMO Open|November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trialsAndrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
JCO Precision Oncology|September 14, 2020
Pathogenic Germline DNA Repair Gene and <i>HOXB13</i> Mutations in Men With Metastatic Prostate CancerJulie L Boyle, Andrew W Hahn, Ashley L Kapron, et al.
European Urology|July 7, 2020
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate CancerUmang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al.
European Urology Oncology|July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 PatientsJustin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
The Oncologist|June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning PlatformEdwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.
Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Plos One|January 26, 2019
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinomaDavid D Stenehjem, Andrew W Hahn, David M Gill, et al.
Pageof 11